NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Advanced Robotic Techniques and Rapid Onsite Evaluation for Minimally Invasive Diagnosis and Next-Generation Sequencing.

NCT07685977

Not Yet RecruitingNA

Sponsor: Vanderbilt University Medical Center

Conditions: Peripheral Pulmonary Lesions (PPLs)

Interventions: Rapid onsite evaluation

Countries: United States

ARTEMIS is a multicenter randomized controlled trial. The goal is to understand whether rapid onsite evaluation during robotic assisted bronchoscopy improves the diagnostic performance of the procedure or not.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* ≥ 18 years of age at time of bronchoscopy
* Undergoing robotic assisted bronchoscopy to biopsy a pulmonary lesion

Exclusion Criteria:

* Declines to participate or inability to provide informed consent.
* Clinician determination that the use of ROSE is required or contraindicated for the optimal care of an individual patient
* Patient enrolled in another trial that requires ROSE for PPL biopsy
* Patient previously consented for this trial
* Pregnant or incarcerated patients

Locations (8)

Chicago, Illinois, United States
Chicago, Illinois, United States
Baltimore, Maryland, United States
Burlington, Massachusetts, United States
New York, New York, United States
Chapel Hill, North Carolina, United States
Charleston, South Carolina, United States
Nashville, Tennessee, United States